Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 45: 1621-1627, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burmeister, J. J.
Right arrow Articles by Arnold, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burmeister, J. J.
Right arrow Articles by Arnold, M. A.
Related Collections
Right arrow Oak Ridge Conference
Right arrow Endocrinology and Metabolism
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 1999;45:1621-1627.)
© 1999 American Association for Clinical Chemistry, Inc.

Articles

Evaluation of Measurement Sites for Noninvasive Blood Glucose Sensing with Near-Infrared Transmission Spectroscopy

Jason J. Burmeister1 and Mark A. Arnolda

Department of Chemistry and Optical Science and Technology Center, University of Iowa, Iowa City, IA 52242.
a Author for correspondence. Fax 319-353-1115; e-mail mark-arnold{at}uiowa.edu

Six putative measurement sites were evaluated for noninvasive sensing of blood glucose by first-overtone near-infrared spectroscopy. The cheek, lower lip, upper lip, nasal septum, tongue, and webbing tissue between the thumb and forefinger were examined. These sites were evaluated on the basis of their chemical and physical properties as they pertain to the noninvasive measurement of glucose. Critical features included the effective optical pathlength of aqueous material within the tissue and the percentage of body fat within the optical path. Aqueous optical paths of 5 mm are required to measure clinically relevant concentrations of glucose in the first-overtone region. All of the tested sites met this requirement. The percentage of body fat affects the signal-to-noise ratio of the measurement and must be minimized for reliable glucose sensing. The webbing tissue contains a considerable amount of fat tissue and is clearly the worse measurement site. All other sites possess substantially less fat, with the least amount of fat in tongue tissue. For this reason, the tongue provides spectra with the highest signal-to-noise ratio and is, therefore, the site of choice on the basis of spectral quality.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
S.-j. Yeh, C. F. Hanna, and O. S. Khalil
Monitoring Blood Glucose Changes in Cutaneous Tissue by Temperature-modulated Localized Reflectance Measurements
Clin. Chem., June 1, 2003; 49(6): 924 - 934.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. V. Eddy and M. A. Arnold
Near-Infrared Spectroscopy for Measuring Urea in Hemodialysis Fluids
Clin. Chem., July 1, 2001; 47(7): 1279 - 1286.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
G. L. Coté
Noninvasive and Minimally-Invasive Optical Monitoring Technologies
J. Nutr., May 1, 2001; 131(5): 1596S - 1604.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.